KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001691102-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
101,400
Total Value
$1,144,190.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 27, 2026 | Exercise/Conversion | 33,800 | $7.07 | $238,966.00 | 263,718 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 27, 2026 | Sale | 33,800 | $26.78 | $905,224.84 | 229,918 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Employee Stock Option (Right to Buy) | Derivative | May 27, 2026 | Exercise/Conversion | 33,800 | $0.00 | $0.00 | 0 | Direct | โ | View Details |